$PDEX
PRO DEX INC Stock $pdex

$pdex Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000155335022000745 Filed on September 08, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$11.09M	$12.62M	$42.04M
YoY Change	11.0%	33.7%	10.55%
Cost Of Revenue	$8.131M	$9.173M	$28.91M
YoY Change	23.95%	45.23%	18.22%
Gross Profit	$2.956M	$3.442M	$13.13M
YoY Change	-13.77%	10.36%	-3.26%
Gross Profit Margin	26.66%	27.28%	31.24%
Selling, General & Admin	$1.077M	$1.513M	$4.994M
YoY Change	-4.69%	13.84%	7.03%
% of Gross Profit	36.43%	43.96%	38.03%
Research & Development	$929.0K	$726.0K	$2.980M
YoY Change	-5.2%	-39.5%	-32.03%
% of Gross Profit	31.43%	21.09%	22.69%
Depreciation & Amortization	$193.0K	$180.0K	$726.0K
YoY Change	4.89%	-3.23%	5.83%
% of Gross Profit	6.53%	5.23%	5.53%
Operating Expenses	$2.006M	$2.239M	$7.974M
YoY Change	-4.93%	-11.47%	-11.89%
Operating Profit	$950.0K	$1.203M	$5.158M
YoY Change	-27.92%	103.9%	13.99%
Interest Expense	$130.0K	$309.0K	-$417.0K
YoY Change	145.28%	-28.97%	-137.87%
% of Operating Profit	13.68%	25.69%	-8.08%
Other Income/Expense, Net	$344.0K		-$417.0K
YoY Change	549.06%
Pretax Income	$1.294M	$1.491M	$4.706M
YoY Change	-5.62%	45.46%	-16.35%
Income Tax	$218.0K	$86.00K	$851.0K
% Of Pretax Income	16.85%	5.77%	18.08%
Net Earnings	$1.076M	$1.405M	$3.855M
YoY Change	1.13%	64.71%	-13.37%
Net Earnings / Revenue	9.71%	11.14%	9.17%
Basic Earnings Per Share	$0.30	$0.51	$1.06
Diluted Earnings Per Share	$0.29	$376.5K	$1.024M
COMMON SHARES
Basic Shares Outstanding	3.619M shares	3.609B shares	3.636M shares
Diluted Shares Outstanding	3.695M shares	3.731B shares	3.763M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.500M	$1.604M	$1.604M
YoY Change	-17.7%	-68.02%	-68.02%
Cash & Equivalents	$2.798M	$849.0K	$849.0K
Short-Term Investments	$2.702M	$755.0K	$755.0K
Other Short-Term Assets	$1.515M	$1.500M	$1.500M
YoY Change	352.24%	139.23%	139.23%
Inventory	$15.66M	$12.68M	$12.68M
Prepaid Expenses		$790.0K
Receivables	$11.05M	$15.38M	$15.38M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.84M	$31.17M	$31.17M
YoY Change	22.36%	24.6%	24.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.852M	$13.42M	$13.42M
YoY Change	-63.97%	4.17%	4.17%
Goodwill
YoY Change
Intangibles	$108.0K	$118.0K
YoY Change		-36.56%
Long-Term Investments	$1.889M	$1.779M	$1.779M
YoY Change	14.07%	4.4%	4.4%
Other Assets	$42.00K	$839.0K	$839.0K
YoY Change	-92.08%	58.3%	58.3%
Total Long-Term Assets	$16.13M	$16.16M	$16.16M
YoY Change	1.79%	5.57%	5.57%
TOTAL ASSETS
Total Short-Term Assets	$31.84M	$31.17M	$31.17M
Total Long-Term Assets	$16.13M	$16.16M	$16.16M
Total Assets	$47.97M	$47.33M	$47.33M
YoY Change	14.57%	17.38%	17.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.549M	$3.761M	$3.761M
YoY Change	43.34%	64.38%	64.38%
Accrued Expenses	$3.245M	$2.751M	$2.751M
YoY Change	47.84%	25.16%	25.16%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.297M	$3.285M	$3.285M
YoY Change	164.18%	165.78%	165.78%
Total Short-Term Liabilities	$11.67M	$10.81M	$10.81M
YoY Change	87.91%	84.09%	84.09%
LONG-TERM LIABILITIES
Long-Term Debt	$9.922M	$10.25M	$10.25M
YoY Change	-11.56%	-11.14%	-11.14%
Other Long-Term Liabilities	$1.954M	$2.598M	$2.598M
YoY Change	-35.96%	-8.17%	-8.17%
Total Long-Term Liabilities	$11.88M	$12.85M	$12.85M
YoY Change	-16.78%	-10.55%	-10.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.67M	$10.81M	$10.81M
Total Long-Term Liabilities	$11.88M	$12.85M	$12.85M
Total Liabilities	$23.55M	$23.66M	$23.66M
YoY Change	14.97%	16.91%	16.91%
SHAREHOLDERS EQUITY
Retained Earnings	$17.06M	$15.99M
YoY Change	19.67%	31.78%
Common Stock	$7.354M	$7.682M
YoY Change		-3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.42M	$23.67M	$23.67M
YoY Change
Total Liabilities & Shareholders Equity	$47.97M	$47.33M	$47.33M
YoY Change	14.57%	17.38%	17.38%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	$1.076M	$1.405M	$3.855M
YoY Change	1.13%	64.71%	-13.37%
Depreciation, Depletion And Amortization	$193.0K	$180.0K	$726.0K
YoY Change	4.89%	-3.23%	5.83%
Cash From Operating Activities	$2.892M	-$5.279M	-$847.0K
YoY Change	7.07%	-831.16%	-59.24%
INVESTING ACTIVITIES
Capital Expenditures	$178.0K	-$368.0K	-$1.638M
YoY Change	-120.99%	-59.02%	-80.19%
Acquisitions
YoY Change
Other Investing Activities	$88.00K	$769.0K	$403.0K
YoY Change	-438.46%	-50.64%	-91.16%
Cash From Investing Activities	-$90.00K	$401.0K	-$1.235M
YoY Change	-89.7%	-40.15%	-66.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$351.0K	-$1.546M
YoY Change		-76.62%	-71.59%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$853.0K	966.0K	-790.0K
YoY Change	129.92%	-162.65%	-125.58%
NET CHANGE
Cash From Operating Activities	$2.892M	-5.279M	-847.0K
Cash From Investing Activities	-$90.00K	401.0K	-1.235M
Cash From Financing Activities	-$853.0K	966.0K	-790.0K
Net Change In Cash	$1.949M	-3.912M	-2.872M
YoY Change	33.86%	2508.0%	6.37%
FREE CASH FLOW
Cash From Operating Activities	$2.892M	-$5.279M	-$847.0K
Capital Expenditures	$178.0K	-$368.0K	-$1.638M
Free Cash Flow	$2.714M	-$4.911M	$791.0K
YoY Change	-23.53%	-403.15%	-87.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000788920
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	pdex	Stock Issued During Period Value With Performance Award Vesting StockIssuedDuringPeriodValueWithPerformanceAwardVesting		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment		usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock		usd
CY2021	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments		usd
CY2021	pdex	Uncertain Tax Positions UncertainTaxPositions		usd
CY2021	pdex	Uncertain Tax Position UncertainTaxPosition		pure
CY2022	pdex	Income Tax Reconciliation Share Based Compensation IncomeTaxReconciliationShareBasedCompensation		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent		pure
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-14942
CY2022	dei	Entity Registrant Name EntityRegistrantName	PRO-DEX, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1261240
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2361 McGaw Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92614
CY2022	dei	City Area Code CityAreaCode	(949)
CY2022	dei	Local Phone Number LocalPhoneNumber	769-3200
CY2022	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2022	dei	Trading Symbol TradingSymbol	PDEX
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	50100000	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3619189	shares
CY2022	dei	Auditor Name AuditorName	Moss Adams LLP
CY2022	dei	Auditor Location AuditorLocation	Irvine, California
CY2022	dei	Auditor Firm AuditorFirmId	659
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	849000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3721000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	755000	usd
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	1295000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15384000	usd
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10933000	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	710000	usd
CY2021Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	193000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	12678000	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	8437000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	790000	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	434000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	31166000	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	25013000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6343000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6437000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4833000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3845000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2248000	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2605000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	118000	usd
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	186000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	797000	usd
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	463000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	1779000	usd
CY2021Q2	us-gaap	Long Term Investments LongTermInvestments	1704000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	67000	usd
CY2022Q2	us-gaap	Assets Assets	47326000	usd
CY2021Q2	us-gaap	Assets Assets	40320000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3761000	usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2288000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2751000	usd
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2198000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	544000	usd
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	397000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1013000	usd
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	150000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3285000	usd
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1236000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11354000	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6269000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2054000	usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2432000	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	10250000	usd
CY2021Q2	us-gaap	Notes Payable NotesPayable	11535000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12304000	usd
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13967000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	23658000	usd
CY2021Q2	us-gaap	Liabilities Liabilities	20236000	usd
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3596131	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3596131	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3645660	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3645660	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	7682000	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	7953000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15986000	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12131000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23668000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	20084000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47326000	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40320000	usd
CY2022	us-gaap	Revenues Revenues	42041000	usd
CY2021	us-gaap	Revenues Revenues	38029000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	28909000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	24454000	usd
CY2022	us-gaap	Gross Profit GrossProfit	13132000	usd
CY2021	us-gaap	Gross Profit GrossProfit	13575000	usd
CY2022	us-gaap	Selling Expense SellingExpense	91000	usd
CY2021	us-gaap	Selling Expense SellingExpense	590000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4903000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4076000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-35000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2980000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4384000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	8009000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9050000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	5123000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	4525000	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	76000	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	126000	usd
CY2022	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-57000	usd
CY2021	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	1371000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	28000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	1327000	usd
CY2022	us-gaap	Interest Expense InterestExpense	464000	usd
CY2021	us-gaap	Interest Expense InterestExpense	352000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-417000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2472000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4706000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6997000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	851000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1176000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3855000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5821000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.53
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3635894	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3796516	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3763345	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3936194	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	19062000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5821000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	57000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	259000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	901000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5537000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	20084000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3855000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	60000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1275000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1606000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23668000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3855000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5821000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	726000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	686000	usd
CY2022	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-57000	usd
CY2021	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	1371000	usd
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	28000	usd
CY2021	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1327000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	84000	usd
CY2022	pdex	Noncash Lease Expense NoncashLeaseExpense	13000	usd
CY2021	pdex	Noncash Lease Expense NoncashLeaseExpense	26000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-35000	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-9000	usd
CY2021	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-49000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1275000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	901000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-334000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-181000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-2000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4449000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5783000	usd
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	517000	usd
CY2021	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	38000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4241000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	199000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	331000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	314000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1991000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	105000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	863000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-50000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	147000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-408000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-847000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2078000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1638000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1769000	usd
CY2021	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	6499000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	770000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4596000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	33000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	38000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	334000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1235000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3710000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1244000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	351000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9139000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1606000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5537000	usd
CY2021	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock	-259000	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	60000	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	96000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-790000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3088000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2872000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2700000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3721000	usd
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6421000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	849000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3721000	usd
CY2022	pdex	Cashless Stock Option Exercise CashlessStockOptionExercise	45000	usd
CY2021	pdex	Cashless Stock Option Exercise CashlessStockOptionExercise	4000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1565000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1767000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	463000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	330000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_zXgdcBX7O39g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 3pc">1.</td><td><span id="xdx_827_zEuSDTlaccDe">DESCRIPTION OF BUSINESS</span></td></tr></table> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"><span id="a_DV_M441"/><span id="a_DV_M442"/>We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial markets. We have patented adaptive torque-limiting technology and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</p>
CY2021	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-25000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	710000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	0	usd
CY2021	us-gaap	Profit Loss ProfitLoss	71000	usd
CY2022	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p id="xdx_843_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zvDKWTqC57n6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86C_z2cihzpBNRWl">Warranties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Certain of our products are sold with a warranty that provides for repairs or replacement of any defective parts for a period, generally one to two years, after the sale. At the time of the sale, we accrue an estimate of the cost of providing the warranty based on prior experience with such factors as return rates and repair costs, which factors are reviewed quarterly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The warranty accrual is based on historical costs of warranty repairs and expected future identifiable warranty expenses and is included in accrued expenses in the accompanying balance sheets. Warranty expenses are included in cost of sales in the accompanying statements of operations. Changes in estimates to previously established warranty accruals result from current period updates to assumptions regarding repair costs and warranty return rates and are included in current period warranty expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p>
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3845000	usd
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	193000	usd
CY2022Q2	us-gaap	Other Inventory In Transit OtherInventoryInTransit	177000	usd
CY2021Q2	us-gaap	Other Inventory In Transit OtherInventoryInTransit	128000	usd
CY2022	us-gaap	Depreciation Depreciation	616000	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zlglILd2Ks85" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pc"><span style="letter-spacing: -0.05pt"><b><span id="xdx_869_zzyJr14CltAk">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pc"><span style="letter-spacing: -0.05pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"><span style="letter-spacing: -0.05pt">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pc"><span style="letter-spacing: -0.05pt"> </span></p>
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	150000	usd
CY2021	us-gaap	Depreciation Depreciation	609000	usd
CY2022Q2	pdex	Retired Assets RetiredAssets	87000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	35000	usd
CY2021Q2	pdex	Retired Assets RetiredAssets	49000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.17	pure
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zOy7EFbLDUj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_867_zzxlhdvn3o89">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Financial instruments that potentially subject us to credit risk consist principally of cash, cash equivalents, and trade receivables. We place our cash and cash equivalents with major financial institutions. At June 30, 2022 and 2021, and throughout the fiscal years then ended, we had deposits in excess of federally insured limits. Credit sales are made to medical device distributors, original equipment manufacturers, and resellers throughout the world, and sales to such customers account for a substantial portion of our trade receivables. While such receivables are not collateralized, we evaluate their collectability based on several factors including customers’ payment histories.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p>
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	193000	usd
CY2020Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	155000	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	1319000	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	458000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zRypZlqBv2Vk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pc"><b><span id="xdx_86C_z2JqVBPY1YOe">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Our operations are affected by numerous factors including market acceptance of our products, supply chain disruptions, changes in technologies, and new laws, effects from the COVID-19 pandemic, government regulations, and policies. We cannot predict what impact, if any, the occurrence of these or other events might have on our operations. Significant estimates and assumptions made by management include, but are not limited to, revenue recognition, share-based compensation, the allowance for doubtful accounts, accrued warranty expense, investments, inventory valuation, the carrying value of long-lived assets, and the recoverability of deferred income tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p>
CY2022	us-gaap	Immaterial Error Correction ImmaterialErrorCorrection	Accordingly, the prior year financial statements have been revised to reflect the impact of ASU 2016-1. The revised classification and reported values of our unrealized gains (losses) on marketable equity investments as accounted for under ASU 2016-01 are included in the consolidated financial statements herein. The impact to net income for the year ended June 30, 2021, was an increase of $1.4 million with a corresponding decrease in unrealized gain on marketable equity securities of $1.4 million, previously presented in other comprehensive income (loss). The revision resulted in an increase to basic earnings per share of $0.36 and diluted earnings per share of $0.35 for the year ended June 30, 2021. As of June 30, 2021, the revision reclassified the remaining accumulated other comprehensive loss of $215,000 to retained earnings.
CY2022	us-gaap	Advertising Expense AdvertisingExpense	1000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	4000	usd
CY2022	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-774000	usd
CY2021	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-395000	usd
CY2022	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-28000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	61000	usd
CY2022Q2	pdex	Investment In Common Stock Affiliated With Company Board Members InvestmentInCommonStockAffiliatedWithCompanyBoardMembers	755000	usd
CY2021Q2	pdex	Investment In Common Stock Affiliated With Company Board Members InvestmentInCommonStockAffiliatedWithCompanyBoardMembers	847000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	976000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	1014000	usd
CY2021	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	324000	usd
CY2022	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	41027000	usd
CY2021	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	37705000	usd
CY2022	us-gaap	Revenues Revenues	42041000	usd
CY2021	us-gaap	Revenues Revenues	38029000	usd
CY2022Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	98000	usd
CY2021Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	50000	usd
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	1000000.0	usd
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	200000	usd
CY2022	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	1482000	usd
CY2022	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-619000	usd
CY2021	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-50000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1013000	usd
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	150000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	755000	usd
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	1295000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	1779000	usd
CY2021Q2	us-gaap	Long Term Investments LongTermInvestments	1704000	usd
CY2022Q2	us-gaap	Marketable Securities MarketableSecurities	2534000	usd
CY2021Q2	us-gaap	Marketable Securities MarketableSecurities	2999000	usd
CY2022Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2796000	usd
CY2021Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	3204000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	262000	usd
CY2022	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	369000	usd
CY2022	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	107000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	205000	usd
CY2021	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	376000	usd
CY2021	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	171000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	6323000	usd
CY2021Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	3967000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3463000	usd
CY2021Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2218000	usd
CY2022Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2118000	usd
CY2021Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	1738000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	774000	usd
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	514000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	12678000	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	8437000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	6499000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	6499000	usd
CY2022Q2	pdex	Accumulated Depreciation AccumulatedDepreciation	-156000	usd
CY2021Q2	pdex	Accumulated Depreciation AccumulatedDepreciation	-62000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6343000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6437000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13177000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11625000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8344000	usd
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7780000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4833000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	90000	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	74000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	118000	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	186000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14000	usd
CY2022	us-gaap	Legal Fees LegalFees	84000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	30000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	509000	usd
CY2021Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	505000	usd
CY2022Q2	pdex	Unvouchered Inventory In Transit Current UnvoucheredInventoryInTransitCurrent	177000	usd
CY2021Q2	pdex	Unvouchered Inventory In Transit Current UnvoucheredInventoryInTransitCurrent	128000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	275000	usd
CY2021Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	124000	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	430000	usd
CY2021Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	300000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	379000	usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	344000	usd
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	340000	usd
CY2021Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	221000	usd
CY2022Q2	pdex	Accrued Losses On Development Contracts Current AccruedLossesOnDevelopmentContractsCurrent	517000	usd
CY2021Q2	pdex	Accrued Losses On Development Contracts Current AccruedLossesOnDevelopmentContractsCurrent	394000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	124000	usd
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	182000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2751000	usd
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2198000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1181000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	221000	usd
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	213000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	177000	usd
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	339000	usd
CY2022	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	54000	usd
CY2021	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-27000	usd
CY2022	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	-112000	usd
CY2021	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	-304000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	340000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	221000	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	231000	usd
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	312000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	733000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1040000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	451000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	340000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-187000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-186000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-146000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-18000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	851000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1176000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4706000	usd
CY2022	pdex	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Tax Rate IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate	1	pure
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6997000	usd
CY2021	pdex	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Tax Rate IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate	1	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	202000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04	pure
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	279000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04	pure
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-205000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.04	pure
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-169000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.03	pure
CY2022	pdex	Uncertain Tax Positions UncertainTaxPositions	-76000	usd
CY2022	pdex	Uncertain Tax Position UncertainTaxPosition	-0.02	pure
CY2021	pdex	Income Tax Reconciliation Share Based Compensation IncomeTaxReconciliationShareBasedCompensation	-93000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.01	pure
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-46000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.01	pure
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-22000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	851000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.18	pure
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1176000	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.17	pure
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	22000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20000	usd
CY2022Q2	pdex	Deferred Tax Assets Research And Other Credits DeferredTaxAssetsResearchAndOtherCredits	65000	usd
CY2021Q2	pdex	Deferred Tax Assets Research And Other Credits DeferredTaxAssetsResearchAndOtherCredits	65000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	163000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	120000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	322000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	293000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	651000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	268000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	35000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	61000	usd
CY2022Q2	pdex	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	713000	usd
CY2021Q2	pdex	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	788000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	514000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	371000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2485000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1986000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	98000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	158000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2387000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1828000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	820000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	523000	usd
CY2022Q2	pdex	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	658000	usd
CY2021Q2	pdex	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	740000	usd
CY2022Q2	pdex	Deferred Tax Liabilities Deferred State Tax DeferredTaxLiabilitiesDeferredStateTax	77000	usd
CY2021Q2	pdex	Deferred Tax Liabilities Deferred State Tax DeferredTaxLiabilitiesDeferredStateTax	38000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	35000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	64000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1590000	usd
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1365000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	797000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	463000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	60000	usd
CY2022Q2	pdex	Unrecognized Tax Benefit UnrecognizedTaxBenefit	509000	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	550000	usd
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	524000	usd
CY2022	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions On Federal Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax	33000	usd
CY2021	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions On Federal Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax	30000	usd
CY2022	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions Upon State Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax	26000	usd
CY2021	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions Upon State Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax	20000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	9000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	109000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	30000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	509000	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	550000	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3293000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1344000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1397000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1451000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1508000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	4597000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	13590000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	379000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	504000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	519000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	535000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	551000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	567000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	143000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2819000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	386000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2433000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053	pure
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	489000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	475000	usd
CY2022	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	559000	usd
CY2021	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	558000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3855000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5821000	usd
CY2022	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3636	shares
CY2021	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3797	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.53
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3855000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5821000	usd
CY2022	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3636	shares
CY2021	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3797	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	127	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	139	shares
CY2022	pdex	Weightedaverage Shares Used In Calculation Of Diluted Earnings Per Share WeightedaverageSharesUsedInCalculationOfDilutedEarningsPerShare	3763	shares
CY2021	pdex	Weightedaverage Shares Used In Calculation Of Diluted Earnings Per Share WeightedaverageSharesUsedInCalculationOfDilutedEarningsPerShare	3936	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48

Files In Submission

Name	View Source	Status
0001553350-22-000745-index-headers.html	Edgar Link	pending
0001553350-22-000745-index.html	Edgar Link	pending
0001553350-22-000745.txt	Edgar Link	pending
0001553350-22-000745-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pdex-20220630.xsd	Edgar Link	pending
pdex_10k.htm	Edgar Link	pending
pdex_ex23z1.htm	Edgar Link	pending
pdex_ex31z1.htm	Edgar Link	pending
pdex_ex31z2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pdex-20220630_cal.xml	Edgar Link	unprocessable
pdex-20220630_def.xml	Edgar Link	unprocessable
pdex-20220630_pre.xml	Edgar Link	unprocessable
pdex-20220630_lab.xml	Edgar Link	unprocessable
pdex_10k_htm.xml	Edgar Link	completed
pdex_ex32.htm	Edgar Link	pending
pdex_ex4z1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PDEX
PRO DEX INC Stock $pdex

2022 Q3 Form 10-K Financial Statement

#000155335022000745 Filed on September 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX PRO DEX INC Stock $pdex

2022 Q3 Form 10-K Financial Statement

#000155335022000745 Filed on September 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX
PRO DEX INC Stock $pdex